Description: Kontafarma China Holdings Limited, an investment holding company, engages in the manufacture and sale of prescription drugs and laboratory related products in Mainland China, Singapore, Taiwan, and the United States. The company operates in Pharmaceutical Business and Fitness Business segments. It also offers chemical drugs and prescribed traditional Chinese medicines; operates fitness centers; operates in the franchise business; and provides consultation services for fitness and health activities. The company trades in laboratory related products; researches and develops medical products; and offers corporate advisory services. As of December 31, 2021, it operated 12 fitness centers and 2 yoga center in Taiwan; and 10 fitness centers in Singapore. The company was formerly known as Tongfang Kontafarma Holdings Limited and changed its name to Kontafarma China Holdings Limited in September 2022. The company was founded in 1993 and is headquartered in Wan Chai, Hong Kong. Kontafarma China Holdings Limited is a subsidiary of China Health Management Investment Limited.
Home Page: www.kontafarma.com.hk
Sun Hung Kai Centre
Wan Chai,
Hong Kong
Phone:
852 2731 6500
Officers
| Name | Title |
|---|---|
| Mr. Pingyan Bai | Exec. Chairman |
| Mr. Chaowen Jiang | VP, CEO & Exec. Director |
| Mr. Yu Huang | Pres & Exec. Director |
| Mr. Hongjie Chai | Exec. Director |
| Ms. Man Wai Si Tou | VP, CFO & Company Sec. |
| Mr. Jie Zhang | VP & COO |
Exchange: HK
Country: HK
Currency: Hong Kong Dollar (HK$)
| GIC Sector: | Materials |
|---|---|
| GIC Group: | Materials |
| GIC Industry: | Construction Materials |
| GIC Sub-Industry: | Construction Materials |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.176 |
| Price-to-Sales TTM: | 0.2068 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 1365 |